Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Solid Biosciences Inc. (SLDB) had Cash Flow from Financial Activities of $287.50M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-54.80M |
|
-- |
|
-- |
|
$57.38M |
|
$-57.38M |
|
$2.58M |
|
$-54.80M |
|
$-54.80M |
|
$-54.80M |
|
$-54.80M |
|
$-54.80M |
|
$-54.80M |
|
$-57.38M |
|
$-58.36M |
|
143.69M |
|
143.69M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$395.11M |
|
$3.96M |
|
$25.47M |
|
$420.58M |
|
$28.58M |
|
-- |
|
$17.92M |
|
$46.51M |
|
$374.07M |
|
$374.07M |
|
$374.07M |
|
105.12M |
|
| Cash Flow Statement Financials | |
$-99.82M |
|
$-88.83M |
|
|
Cash Flow from Financial Activities |
$287.50M |
$61.89M |
|
$160.74M |
|
$98.85M |
|
$10.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-100.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.65% |
|
-14.65% |
|
-13.03% |
|
-14.65% |
|
$3.56 |
|
$-0.70 |
|
$-0.69 |
|